SlideShare a Scribd company logo
1 of 31
Gollis University
Faculty of Agriculture and Veterinary
Medicine
Introduction to Veterinary
Pharmacology
LECTURER: Dr.Osman Abdulahi Farah
Date: 24 th nov 2014
Introduction
Pharmacology can be defined as the study of
substances that interact with living systems
through chemical process, by binding to
regulatory molecules activity or inhibiting normal
body process.
 applications may be considered the proper role of
Veterinary pharmacology, which is often
defined as the science of substances used to
prevent, diagnose, and treat disease for live
animals.
 Toxicology is that branch of pharmacology
which deals with the undesirable effects of
chemicals on living systems, from individual cells
to complex ecosystems.
introduction
Veterinary Pharmacology is divided into two main
subdivisions, pharmacokinetics and
pharmacodynamics .
1.Pharmacodynamics is the study of the
actions of drug on target organs. nd way of
thinking about it is that
pharmacodynamics (PD)is what the drug does to
the body,
Vet Pharmacokinetics(PK)
Vet Pharmacokinetics is What the body does to drug
 Modern pharmacology is focused on the
biochemical and molecular mechanisms by which
drugs produce their physiologic effects and with
the dose-response relationship , defined as
the relationship between the concentration of a
drug in a tissue and the magnitude of the tissue’s
response to that drug.
continue
Most Vet drugs produce their effects
by binding to protein receptors in
target tissues, a process that
activates a flow of events known
as signal transduction .
Vet Drug Nomenclature
Example 1: the chemical name 2-methyl-5-
nitroimidazole-l-ethanol is metronidazole. The
word methylnitro is condensed to metro and ni-
dazole is due to its imidazole ring
Example 2: Metoclopramide is the condensed form
of the word methoxychloroprocainamide: where
Me is retained and th is written as t; chloro is
written as clo: and procainamide is written as
pramide
 Chemical name  represents the exact description of
the drug’s chemical composition
Generic name
Generic name
Name that was established when drug
was first manufactured
Written in lowercase letters
Official name of a drug
Each drug has only one generic name
Original manufacturer is only company
that can use generic name for the first
17 years
continue
 Brand or trade name  is developed by the company
requesting approval for the drug and identifies it as the
exclusive property of that company.
 Is Name under which the drug is sold by a specific
manufacturer
 Spelling always begins with a capital letter
 Name is owned by the drug company and no other
company may use that name
 Example 1: Metrogyl® is the trade name for metronidazole.
 Example 2: Reglan® is the trade name for Metoclopramide.
 Example 3: Amoxil® is the trade name for amoxycillin.
 Example 4: Celebrex® is the trade name for Celecoxib
Pharmacokinetics is the
description of the time course of a
drug in the body, encompassing
Absorption, Distribution, Metabolism,
and excretion/Elimination. ADME
In simplest terms, it can be described
as what the body does to the drug.
The relationship between these
subdivisions and tissues over time,
including drug absorption,
distribution,
biotransformation (metabolism) ,
and excretion .
Absorption
 It is the passage of drug from the site of
administration into the circulation.
 Bioavailability: is the extend to which a drug reaches its site of
action or to biological fluid such as plasma from which the drug
has access to its site of action
 Aqueous solubility. Drugs given in solid
form must dissolve in the aqueous
biophase before they are absorbed. For
poorly water soluble drugs (aspirin,
griseofulvin) the rate of dissolution
governs the rate of absorption. If a drug is
given as water solution, it is absorbed
faster than the same given in solid form or
continue
 Concentration. Passive transport depends
on the concentration gradient. A drug
given as concentrated solution is absorbed
faster than dilute solution.
 Area of absorbing surface. If the area is
larger, the absorption is faster
 Route of administration affects drug
 absorption, because each route has its
 own custom
Continue
 Oral application. Unionized lipid soluble
drugs (e.g.ethanol) are readily absorbed
from GIT. Acid drugs (aspirin,
barbiturates, etc.) are predominantly
unionized in the acid gastric juice and are
absorbed from the stomach. Acid
 drugs absorption from the stomach is
slower, because the mucosa is thick,
covered with mucus and the surface is
small
Factors affect drug absorption
1.dose , concentration of rate
administration
2. Dosage form
3. Physical and chemical properties
4. Route of administration
Distribution
 Distribution: is the passage of a drug from
the circulation
 to the tissue and the site of its action.
 The extent of distribution of a drug
depends on its lipid solubility, ionization at
physiological pH (dependent on pK),
extent of binding to plasma and tissue
proteins, and differences in regional blood.
flow, disease like CHF, uremia,
cirrhosis. Movement of a drug
proceeds until an equilibration is
established between unbound drug in
plasma and tissue fluids
 Body fluid compartments
The total body water as a percentage of
body mass varies from 50% to 70%,
being rather less in women than in man.
 Body water is distributed into the
following main compartments
Metabolism(Biotransformation)
 Metabolism includes chemical alteration of the
drugs in the body. Most hydrophilic drugs
(amikacin, gentamycin, neostigmine, mannitol)
are not biotransformated and are excreted
unchanged. The mechanism to metabolize drugs
is developed to protect the body from toxins.
The primary site for drug metabolism is the liver,
other sites are the kidney, intestine, lungs, and
plasma
 Biotransformation reactions can be classified into
two phases: I (no synthetic) and II (synthetic,
conjugation).
Excretion
 Excretion is the passage out of
 systematically absorbed drugs.
 Vet Drugs and their metabolites
 are excreted in:
 urine (through the kidney)
• bile and faeces
• exhaled air
• saliva and sweat,milk and skin
kidney
 The kidney is responsible for excreting all water soluble
substances.
Glomerular filtration. Glomerular capillaries have large pores.
All nonprotein bound drugs (lipid soluble or insoluble)
presented to the glomerulus are filtrated. Glomerular
filtration of drugs depends on their plasma protein binding
and renal blood flow. Glomerular filtration rate (g.f.r.)
declines progressively after the age of 50 and is low in
renal failure.
 Tubular reabsorption. Lipid soluble drugs filtrated at the
glomerulus back diffuse in the tubules because 99% of
glomerular filtrate is reabsorbed, but nonlipid soluble and
highly ionized drugs are unable to do so.
continue
 The effect of changes in urinary pH on drug excretion
 is greatest for a drug having pK values between 5 to 8,
 because only in this case pH dependent passive
 reabsorption is significant.
 Tubular secretion is the active transfer of organic acid and
bases by two separate nonspecific mechanisms, which
operate in the proximal tubules:
• Organic acid transport for penicillins,, methotrexate, drug
glucuronides, etc.
• Organic base transport for thiazides, quinine,
 procainamide, cimetidine, amiloride, etc.
Pharmacodynamics
Vet Pharmacodynamics is the
study of the biochemical and
physiological effects of drugs, in
certain period.
In brief, it can be described as what
the drug does to the body.
Drug receptors
Effects of drug
Responses to drugs
Toxicity and adverse effects of drugs
Drug Receptor Interactions
The Lock and Key Model of Signal-Receptor
Interaction
 Ligands such as hormones or neurotransmitters
(the"key") affect target cells by binding to specific
receptors (the "lock”), which are often located in
the cell membrane of animal body
 This binding "unlocks" the cell's response, so that
the hormone or neurotransmitter can exert its
effects
 Agonist
“A chemical messenger that binds to a receptor
and triggers the cell’s response; often refers to
a drug that mimics a normal messenger’s action”.
 For example, pilocarpine is a muscarinic receptor agonist
because it can bind to and activate muscarinic receptors
Drug Receptors
 Receptor/Binding site
“A specific protein in either the plasma
membrane or interior of a target cell with which
a ligand/drug combines”
 It must be selective in choosing
ligands/drugs to bind  To avoid constant
activation of the receptor by promiscuous
binding of many different ligands (drugs)
 It must change its function upon binding in
such a way that the function of the biologic
system (cell, tissue, etc) is altered  This is
necessary for the ligand (drug) to cause a
pharmacologic effect
 Antagonist is "A molecule that competes for a receptor
with a chemical messenger normally present in the body.
The antagonist binds to the receptor but does not trigger
the cell’s response”
 For Example, atropine is a muscarinic receptor antagonist
because it can bind to muscarinic receptors but it does not
trigger the cell’s response. In this way, it prevents binding of
acetylcholine (ACh) and similar agonist drugs to the ACh recept
 Any drug will be toxic once they are overdosed.
 toxic dose; lethal dose
Drug Receptor Interactions
Agonist Receptor
Agonist-
Receptor
Lock and key mechanism
 Receptor
“A specific protein in either the plasma membrane or interior of a
target cell with which a chemical messenger/drug combines”
Terminology of Pharmacology,
 Drug
“Any substance that brings about a change in biologic function
through its chemical actions”a
 Dose
“The amount of a drug to be administered at one time”
Duration
“The time a drug concentration is sufficient to elicit a
therapeutic response
 Mechanism of Action
“The ways by which drugs can produce therapeutic
effects”
continue
 Effects (therapeutic effect)
“The desired results of administration of a medication”
 Side Effects (adverse effects)
“Effects that are harmful and undesired, and that occur in addition
to the desired therapeutic effects”
 Indications
“The reasons for administering a medication or performing a
treatment”
Contra-indications
“Factor that prevents the use of a medication or treatment (
e.g., Allergies)”
continue
 Onset
“The time it takes for the drug to elicit a therapeutic
response
Bioavailability: is the extend to which a drug reaches its
site of action
 Pharmacotherapeutics is the medical science concerned
with
 the use of drugs in the treatment of disease.
 Pharmacognosy is the study of drugs isolated from
natural sources, including plants, microbes, animal tissues
introductionofpharmacology-141126031620-conversion-gate01.ppt

More Related Content

Similar to introductionofpharmacology-141126031620-conversion-gate01.ppt

Presentation1.pptx
Presentation1.pptxPresentation1.pptx
Presentation1.pptxayman255825
 
Pharmacokinetics and Pharmacodynamic- General Pharmacology Ravinandan A P
Pharmacokinetics and Pharmacodynamic- General Pharmacology Ravinandan A PPharmacokinetics and Pharmacodynamic- General Pharmacology Ravinandan A P
Pharmacokinetics and Pharmacodynamic- General Pharmacology Ravinandan A PRavinandan A P
 
Introduction to pharmacokinetics and pharmacodynamics principles
Introduction to pharmacokinetics and pharmacodynamics principlesIntroduction to pharmacokinetics and pharmacodynamics principles
Introduction to pharmacokinetics and pharmacodynamics principlespooranachithra flowry
 
Pharmacotherapeutics chapter 1 topic 1.pptx
Pharmacotherapeutics chapter 1 topic 1.pptxPharmacotherapeutics chapter 1 topic 1.pptx
Pharmacotherapeutics chapter 1 topic 1.pptxAlka187671
 
Lecture1 100717171756-phpapp01
Lecture1 100717171756-phpapp01Lecture1 100717171756-phpapp01
Lecture1 100717171756-phpapp01Cleophas Rwemera
 
Clinical pharmacology.Basics.
Clinical pharmacology.Basics.Clinical pharmacology.Basics.
Clinical pharmacology.Basics.Eugene Shorikov
 
Intro to pharmacology
Intro to pharmacologyIntro to pharmacology
Intro to pharmacologyDr Shah Murad
 
physicochemical properties of Drug (1).ppt
physicochemical properties of Drug (1).pptphysicochemical properties of Drug (1).ppt
physicochemical properties of Drug (1).pptsaumyashuka
 
Introduction_to_Pharmacology_subject.ppt
Introduction_to_Pharmacology_subject.pptIntroduction_to_Pharmacology_subject.ppt
Introduction_to_Pharmacology_subject.pptbreenaawan
 
Drugs pharmaceutical compounds
Drugs pharmaceutical compounds Drugs pharmaceutical compounds
Drugs pharmaceutical compounds Fayza Syed
 
OCCULAR PHARMACOLOGY.pptx
OCCULAR PHARMACOLOGY.pptxOCCULAR PHARMACOLOGY.pptx
OCCULAR PHARMACOLOGY.pptxgeniousg1
 
Pharmacology ppt
Pharmacology pptPharmacology ppt
Pharmacology pptminati das
 
Pharmacology ppt
Pharmacology pptPharmacology ppt
Pharmacology pptminati das
 
ALL CHAPTERS OF PHARMACOLOGY.pptx
ALL CHAPTERS OF PHARMACOLOGY.pptxALL CHAPTERS OF PHARMACOLOGY.pptx
ALL CHAPTERS OF PHARMACOLOGY.pptxDrAbdikadirOsman1
 
Mechanism of drug action & factor modifying drug action
Mechanism of drug action & factor modifying drug actionMechanism of drug action & factor modifying drug action
Mechanism of drug action & factor modifying drug actionDipak Bari
 
General pharmacology
General pharmacologyGeneral pharmacology
General pharmacologySADDA_HAQ
 

Similar to introductionofpharmacology-141126031620-conversion-gate01.ppt (20)

Presentation1.pptx
Presentation1.pptxPresentation1.pptx
Presentation1.pptx
 
Pharmacokinetics and Pharmacodynamic- General Pharmacology Ravinandan A P
Pharmacokinetics and Pharmacodynamic- General Pharmacology Ravinandan A PPharmacokinetics and Pharmacodynamic- General Pharmacology Ravinandan A P
Pharmacokinetics and Pharmacodynamic- General Pharmacology Ravinandan A P
 
Introduction to pharmacokinetics and pharmacodynamics principles
Introduction to pharmacokinetics and pharmacodynamics principlesIntroduction to pharmacokinetics and pharmacodynamics principles
Introduction to pharmacokinetics and pharmacodynamics principles
 
Pharmacotherapeutics chapter 1 topic 1.pptx
Pharmacotherapeutics chapter 1 topic 1.pptxPharmacotherapeutics chapter 1 topic 1.pptx
Pharmacotherapeutics chapter 1 topic 1.pptx
 
Lecture1 100717171756-phpapp01
Lecture1 100717171756-phpapp01Lecture1 100717171756-phpapp01
Lecture1 100717171756-phpapp01
 
1 general pharmacology
1 general pharmacology1 general pharmacology
1 general pharmacology
 
Clinical pharmacology.Basics.
Clinical pharmacology.Basics.Clinical pharmacology.Basics.
Clinical pharmacology.Basics.
 
Intro to pharmacology
Intro to pharmacologyIntro to pharmacology
Intro to pharmacology
 
Lecture 1
Lecture 1Lecture 1
Lecture 1
 
Pharmacology
Pharmacology  Pharmacology
Pharmacology
 
physicochemical properties of Drug (1).ppt
physicochemical properties of Drug (1).pptphysicochemical properties of Drug (1).ppt
physicochemical properties of Drug (1).ppt
 
Introduction_to_Pharmacology_subject.ppt
Introduction_to_Pharmacology_subject.pptIntroduction_to_Pharmacology_subject.ppt
Introduction_to_Pharmacology_subject.ppt
 
Drugs pharmaceutical compounds
Drugs pharmaceutical compounds Drugs pharmaceutical compounds
Drugs pharmaceutical compounds
 
OCCULAR PHARMACOLOGY.pptx
OCCULAR PHARMACOLOGY.pptxOCCULAR PHARMACOLOGY.pptx
OCCULAR PHARMACOLOGY.pptx
 
Pharmacology ppt
Pharmacology pptPharmacology ppt
Pharmacology ppt
 
Pharmacology ppt
Pharmacology pptPharmacology ppt
Pharmacology ppt
 
Pharmacology
Pharmacology Pharmacology
Pharmacology
 
ALL CHAPTERS OF PHARMACOLOGY.pptx
ALL CHAPTERS OF PHARMACOLOGY.pptxALL CHAPTERS OF PHARMACOLOGY.pptx
ALL CHAPTERS OF PHARMACOLOGY.pptx
 
Mechanism of drug action & factor modifying drug action
Mechanism of drug action & factor modifying drug actionMechanism of drug action & factor modifying drug action
Mechanism of drug action & factor modifying drug action
 
General pharmacology
General pharmacologyGeneral pharmacology
General pharmacology
 

More from juuisha

CID_Emerging and Re-emerging Diseases of Livestock.pptx
CID_Emerging and Re-emerging Diseases of Livestock.pptxCID_Emerging and Re-emerging Diseases of Livestock.pptx
CID_Emerging and Re-emerging Diseases of Livestock.pptxjuuisha
 
1-5-emerging-and-reemerging-swine-diseases_ni.pptx
1-5-emerging-and-reemerging-swine-diseases_ni.pptx1-5-emerging-and-reemerging-swine-diseases_ni.pptx
1-5-emerging-and-reemerging-swine-diseases_ni.pptxjuuisha
 
Nutraceuticals_ cid.pptx
Nutraceuticals_ cid.pptxNutraceuticals_ cid.pptx
Nutraceuticals_ cid.pptxjuuisha
 
CS-211 Advanced Crop Production and Management legumes.pptx
CS-211 Advanced Crop Production and Management legumes.pptxCS-211 Advanced Crop Production and Management legumes.pptx
CS-211 Advanced Crop Production and Management legumes.pptxjuuisha
 
IPM.pptx
IPM.pptxIPM.pptx
IPM.pptxjuuisha
 
2007 Non-Human Primates_unlocked.pptx
2007 Non-Human Primates_unlocked.pptx2007 Non-Human Primates_unlocked.pptx
2007 Non-Human Primates_unlocked.pptxjuuisha
 
recentadvancesinanimalbiotechnologyconfrenceppt.pptx
recentadvancesinanimalbiotechnologyconfrenceppt.pptxrecentadvancesinanimalbiotechnologyconfrenceppt.pptx
recentadvancesinanimalbiotechnologyconfrenceppt.pptxjuuisha
 
3.15_Drug_Formulary_for_Primates_and_Primate_Sanctuaries.pdf
3.15_Drug_Formulary_for_Primates_and_Primate_Sanctuaries.pdf3.15_Drug_Formulary_for_Primates_and_Primate_Sanctuaries.pdf
3.15_Drug_Formulary_for_Primates_and_Primate_Sanctuaries.pdfjuuisha
 
Making-effective-power-point-presentation.pptx
Making-effective-power-point-presentation.pptxMaking-effective-power-point-presentation.pptx
Making-effective-power-point-presentation.pptxjuuisha
 
21_GENETIC_BASIS_OF_DEVELOPMENT_ppt (1).ppt
21_GENETIC_BASIS_OF_DEVELOPMENT_ppt (1).ppt21_GENETIC_BASIS_OF_DEVELOPMENT_ppt (1).ppt
21_GENETIC_BASIS_OF_DEVELOPMENT_ppt (1).pptjuuisha
 
sex determination.ppt
sex determination.pptsex determination.ppt
sex determination.pptjuuisha
 
PBIO4500 Animal Genetic Engineering.ppt
PBIO4500 Animal Genetic Engineering.pptPBIO4500 Animal Genetic Engineering.ppt
PBIO4500 Animal Genetic Engineering.pptjuuisha
 
Sex Determination.ppt
Sex Determination.pptSex Determination.ppt
Sex Determination.pptjuuisha
 
linkage.ppt
linkage.pptlinkage.ppt
linkage.pptjuuisha
 
PPD SSI Denmark.pdf
PPD SSI Denmark.pdfPPD SSI Denmark.pdf
PPD SSI Denmark.pdfjuuisha
 
Administration_drugs.ppt
Administration_drugs.pptAdministration_drugs.ppt
Administration_drugs.pptjuuisha
 
Physiological factors in fertility of birds.pdf
Physiological factors in fertility of birds.pdfPhysiological factors in fertility of birds.pdf
Physiological factors in fertility of birds.pdfjuuisha
 

More from juuisha (17)

CID_Emerging and Re-emerging Diseases of Livestock.pptx
CID_Emerging and Re-emerging Diseases of Livestock.pptxCID_Emerging and Re-emerging Diseases of Livestock.pptx
CID_Emerging and Re-emerging Diseases of Livestock.pptx
 
1-5-emerging-and-reemerging-swine-diseases_ni.pptx
1-5-emerging-and-reemerging-swine-diseases_ni.pptx1-5-emerging-and-reemerging-swine-diseases_ni.pptx
1-5-emerging-and-reemerging-swine-diseases_ni.pptx
 
Nutraceuticals_ cid.pptx
Nutraceuticals_ cid.pptxNutraceuticals_ cid.pptx
Nutraceuticals_ cid.pptx
 
CS-211 Advanced Crop Production and Management legumes.pptx
CS-211 Advanced Crop Production and Management legumes.pptxCS-211 Advanced Crop Production and Management legumes.pptx
CS-211 Advanced Crop Production and Management legumes.pptx
 
IPM.pptx
IPM.pptxIPM.pptx
IPM.pptx
 
2007 Non-Human Primates_unlocked.pptx
2007 Non-Human Primates_unlocked.pptx2007 Non-Human Primates_unlocked.pptx
2007 Non-Human Primates_unlocked.pptx
 
recentadvancesinanimalbiotechnologyconfrenceppt.pptx
recentadvancesinanimalbiotechnologyconfrenceppt.pptxrecentadvancesinanimalbiotechnologyconfrenceppt.pptx
recentadvancesinanimalbiotechnologyconfrenceppt.pptx
 
3.15_Drug_Formulary_for_Primates_and_Primate_Sanctuaries.pdf
3.15_Drug_Formulary_for_Primates_and_Primate_Sanctuaries.pdf3.15_Drug_Formulary_for_Primates_and_Primate_Sanctuaries.pdf
3.15_Drug_Formulary_for_Primates_and_Primate_Sanctuaries.pdf
 
Making-effective-power-point-presentation.pptx
Making-effective-power-point-presentation.pptxMaking-effective-power-point-presentation.pptx
Making-effective-power-point-presentation.pptx
 
21_GENETIC_BASIS_OF_DEVELOPMENT_ppt (1).ppt
21_GENETIC_BASIS_OF_DEVELOPMENT_ppt (1).ppt21_GENETIC_BASIS_OF_DEVELOPMENT_ppt (1).ppt
21_GENETIC_BASIS_OF_DEVELOPMENT_ppt (1).ppt
 
sex determination.ppt
sex determination.pptsex determination.ppt
sex determination.ppt
 
PBIO4500 Animal Genetic Engineering.ppt
PBIO4500 Animal Genetic Engineering.pptPBIO4500 Animal Genetic Engineering.ppt
PBIO4500 Animal Genetic Engineering.ppt
 
Sex Determination.ppt
Sex Determination.pptSex Determination.ppt
Sex Determination.ppt
 
linkage.ppt
linkage.pptlinkage.ppt
linkage.ppt
 
PPD SSI Denmark.pdf
PPD SSI Denmark.pdfPPD SSI Denmark.pdf
PPD SSI Denmark.pdf
 
Administration_drugs.ppt
Administration_drugs.pptAdministration_drugs.ppt
Administration_drugs.ppt
 
Physiological factors in fertility of birds.pdf
Physiological factors in fertility of birds.pdfPhysiological factors in fertility of birds.pdf
Physiological factors in fertility of birds.pdf
 

Recently uploaded

Scheme-of-Work-Science-Stage-4 cambridge science.docx
Scheme-of-Work-Science-Stage-4 cambridge science.docxScheme-of-Work-Science-Stage-4 cambridge science.docx
Scheme-of-Work-Science-Stage-4 cambridge science.docxyaramohamed343013
 
Transposable elements in prokaryotes.ppt
Transposable elements in prokaryotes.pptTransposable elements in prokaryotes.ppt
Transposable elements in prokaryotes.pptArshadWarsi13
 
User Guide: Pulsar™ Weather Station (Columbia Weather Systems)
User Guide: Pulsar™ Weather Station (Columbia Weather Systems)User Guide: Pulsar™ Weather Station (Columbia Weather Systems)
User Guide: Pulsar™ Weather Station (Columbia Weather Systems)Columbia Weather Systems
 
Base editing, prime editing, Cas13 & RNA editing and organelle base editing
Base editing, prime editing, Cas13 & RNA editing and organelle base editingBase editing, prime editing, Cas13 & RNA editing and organelle base editing
Base editing, prime editing, Cas13 & RNA editing and organelle base editingNetHelix
 
LIGHT-PHENOMENA-BY-CABUALDIONALDOPANOGANCADIENTE-CONDEZA (1).pptx
LIGHT-PHENOMENA-BY-CABUALDIONALDOPANOGANCADIENTE-CONDEZA (1).pptxLIGHT-PHENOMENA-BY-CABUALDIONALDOPANOGANCADIENTE-CONDEZA (1).pptx
LIGHT-PHENOMENA-BY-CABUALDIONALDOPANOGANCADIENTE-CONDEZA (1).pptxmalonesandreagweneth
 
Citronella presentation SlideShare mani upadhyay
Citronella presentation SlideShare mani upadhyayCitronella presentation SlideShare mani upadhyay
Citronella presentation SlideShare mani upadhyayupadhyaymani499
 
Pests of soyabean_Binomics_IdentificationDr.UPR.pdf
Pests of soyabean_Binomics_IdentificationDr.UPR.pdfPests of soyabean_Binomics_IdentificationDr.UPR.pdf
Pests of soyabean_Binomics_IdentificationDr.UPR.pdfPirithiRaju
 
Grafana in space: Monitoring Japan's SLIM moon lander in real time
Grafana in space: Monitoring Japan's SLIM moon lander  in real timeGrafana in space: Monitoring Japan's SLIM moon lander  in real time
Grafana in space: Monitoring Japan's SLIM moon lander in real timeSatoshi NAKAHIRA
 
Best Call Girls In Sector 29 Gurgaon❤️8860477959 EscorTs Service In 24/7 Delh...
Best Call Girls In Sector 29 Gurgaon❤️8860477959 EscorTs Service In 24/7 Delh...Best Call Girls In Sector 29 Gurgaon❤️8860477959 EscorTs Service In 24/7 Delh...
Best Call Girls In Sector 29 Gurgaon❤️8860477959 EscorTs Service In 24/7 Delh...lizamodels9
 
FREE NURSING BUNDLE FOR NURSES.PDF by na
FREE NURSING BUNDLE FOR NURSES.PDF by naFREE NURSING BUNDLE FOR NURSES.PDF by na
FREE NURSING BUNDLE FOR NURSES.PDF by naJASISJULIANOELYNV
 
Pests of Blackgram, greengram, cowpea_Dr.UPR.pdf
Pests of Blackgram, greengram, cowpea_Dr.UPR.pdfPests of Blackgram, greengram, cowpea_Dr.UPR.pdf
Pests of Blackgram, greengram, cowpea_Dr.UPR.pdfPirithiRaju
 
Bentham & Hooker's Classification. along with the merits and demerits of the ...
Bentham & Hooker's Classification. along with the merits and demerits of the ...Bentham & Hooker's Classification. along with the merits and demerits of the ...
Bentham & Hooker's Classification. along with the merits and demerits of the ...Nistarini College, Purulia (W.B) India
 
BUMI DAN ANTARIKSA PROJEK IPAS SMK KELAS X.pdf
BUMI DAN ANTARIKSA PROJEK IPAS SMK KELAS X.pdfBUMI DAN ANTARIKSA PROJEK IPAS SMK KELAS X.pdf
BUMI DAN ANTARIKSA PROJEK IPAS SMK KELAS X.pdfWildaNurAmalia2
 
User Guide: Orion™ Weather Station (Columbia Weather Systems)
User Guide: Orion™ Weather Station (Columbia Weather Systems)User Guide: Orion™ Weather Station (Columbia Weather Systems)
User Guide: Orion™ Weather Station (Columbia Weather Systems)Columbia Weather Systems
 
Solution chemistry, Moral and Normal solutions
Solution chemistry, Moral and Normal solutionsSolution chemistry, Moral and Normal solutions
Solution chemistry, Moral and Normal solutionsHajira Mahmood
 
BIOETHICS IN RECOMBINANT DNA TECHNOLOGY.
BIOETHICS IN RECOMBINANT DNA TECHNOLOGY.BIOETHICS IN RECOMBINANT DNA TECHNOLOGY.
BIOETHICS IN RECOMBINANT DNA TECHNOLOGY.PraveenaKalaiselvan1
 
User Guide: Capricorn FLX™ Weather Station
User Guide: Capricorn FLX™ Weather StationUser Guide: Capricorn FLX™ Weather Station
User Guide: Capricorn FLX™ Weather StationColumbia Weather Systems
 
Call Girls In Nihal Vihar Delhi ❤️8860477959 Looking Escorts In 24/7 Delhi NCR
Call Girls In Nihal Vihar Delhi ❤️8860477959 Looking Escorts In 24/7 Delhi NCRCall Girls In Nihal Vihar Delhi ❤️8860477959 Looking Escorts In 24/7 Delhi NCR
Call Girls In Nihal Vihar Delhi ❤️8860477959 Looking Escorts In 24/7 Delhi NCRlizamodels9
 
Environmental Biotechnology Topic:- Microbial Biosensor
Environmental Biotechnology Topic:- Microbial BiosensorEnvironmental Biotechnology Topic:- Microbial Biosensor
Environmental Biotechnology Topic:- Microbial Biosensorsonawaneprad
 

Recently uploaded (20)

Scheme-of-Work-Science-Stage-4 cambridge science.docx
Scheme-of-Work-Science-Stage-4 cambridge science.docxScheme-of-Work-Science-Stage-4 cambridge science.docx
Scheme-of-Work-Science-Stage-4 cambridge science.docx
 
Transposable elements in prokaryotes.ppt
Transposable elements in prokaryotes.pptTransposable elements in prokaryotes.ppt
Transposable elements in prokaryotes.ppt
 
User Guide: Pulsar™ Weather Station (Columbia Weather Systems)
User Guide: Pulsar™ Weather Station (Columbia Weather Systems)User Guide: Pulsar™ Weather Station (Columbia Weather Systems)
User Guide: Pulsar™ Weather Station (Columbia Weather Systems)
 
Base editing, prime editing, Cas13 & RNA editing and organelle base editing
Base editing, prime editing, Cas13 & RNA editing and organelle base editingBase editing, prime editing, Cas13 & RNA editing and organelle base editing
Base editing, prime editing, Cas13 & RNA editing and organelle base editing
 
LIGHT-PHENOMENA-BY-CABUALDIONALDOPANOGANCADIENTE-CONDEZA (1).pptx
LIGHT-PHENOMENA-BY-CABUALDIONALDOPANOGANCADIENTE-CONDEZA (1).pptxLIGHT-PHENOMENA-BY-CABUALDIONALDOPANOGANCADIENTE-CONDEZA (1).pptx
LIGHT-PHENOMENA-BY-CABUALDIONALDOPANOGANCADIENTE-CONDEZA (1).pptx
 
Citronella presentation SlideShare mani upadhyay
Citronella presentation SlideShare mani upadhyayCitronella presentation SlideShare mani upadhyay
Citronella presentation SlideShare mani upadhyay
 
Pests of soyabean_Binomics_IdentificationDr.UPR.pdf
Pests of soyabean_Binomics_IdentificationDr.UPR.pdfPests of soyabean_Binomics_IdentificationDr.UPR.pdf
Pests of soyabean_Binomics_IdentificationDr.UPR.pdf
 
Grafana in space: Monitoring Japan's SLIM moon lander in real time
Grafana in space: Monitoring Japan's SLIM moon lander  in real timeGrafana in space: Monitoring Japan's SLIM moon lander  in real time
Grafana in space: Monitoring Japan's SLIM moon lander in real time
 
Volatile Oils Pharmacognosy And Phytochemistry -I
Volatile Oils Pharmacognosy And Phytochemistry -IVolatile Oils Pharmacognosy And Phytochemistry -I
Volatile Oils Pharmacognosy And Phytochemistry -I
 
Best Call Girls In Sector 29 Gurgaon❤️8860477959 EscorTs Service In 24/7 Delh...
Best Call Girls In Sector 29 Gurgaon❤️8860477959 EscorTs Service In 24/7 Delh...Best Call Girls In Sector 29 Gurgaon❤️8860477959 EscorTs Service In 24/7 Delh...
Best Call Girls In Sector 29 Gurgaon❤️8860477959 EscorTs Service In 24/7 Delh...
 
FREE NURSING BUNDLE FOR NURSES.PDF by na
FREE NURSING BUNDLE FOR NURSES.PDF by naFREE NURSING BUNDLE FOR NURSES.PDF by na
FREE NURSING BUNDLE FOR NURSES.PDF by na
 
Pests of Blackgram, greengram, cowpea_Dr.UPR.pdf
Pests of Blackgram, greengram, cowpea_Dr.UPR.pdfPests of Blackgram, greengram, cowpea_Dr.UPR.pdf
Pests of Blackgram, greengram, cowpea_Dr.UPR.pdf
 
Bentham & Hooker's Classification. along with the merits and demerits of the ...
Bentham & Hooker's Classification. along with the merits and demerits of the ...Bentham & Hooker's Classification. along with the merits and demerits of the ...
Bentham & Hooker's Classification. along with the merits and demerits of the ...
 
BUMI DAN ANTARIKSA PROJEK IPAS SMK KELAS X.pdf
BUMI DAN ANTARIKSA PROJEK IPAS SMK KELAS X.pdfBUMI DAN ANTARIKSA PROJEK IPAS SMK KELAS X.pdf
BUMI DAN ANTARIKSA PROJEK IPAS SMK KELAS X.pdf
 
User Guide: Orion™ Weather Station (Columbia Weather Systems)
User Guide: Orion™ Weather Station (Columbia Weather Systems)User Guide: Orion™ Weather Station (Columbia Weather Systems)
User Guide: Orion™ Weather Station (Columbia Weather Systems)
 
Solution chemistry, Moral and Normal solutions
Solution chemistry, Moral and Normal solutionsSolution chemistry, Moral and Normal solutions
Solution chemistry, Moral and Normal solutions
 
BIOETHICS IN RECOMBINANT DNA TECHNOLOGY.
BIOETHICS IN RECOMBINANT DNA TECHNOLOGY.BIOETHICS IN RECOMBINANT DNA TECHNOLOGY.
BIOETHICS IN RECOMBINANT DNA TECHNOLOGY.
 
User Guide: Capricorn FLX™ Weather Station
User Guide: Capricorn FLX™ Weather StationUser Guide: Capricorn FLX™ Weather Station
User Guide: Capricorn FLX™ Weather Station
 
Call Girls In Nihal Vihar Delhi ❤️8860477959 Looking Escorts In 24/7 Delhi NCR
Call Girls In Nihal Vihar Delhi ❤️8860477959 Looking Escorts In 24/7 Delhi NCRCall Girls In Nihal Vihar Delhi ❤️8860477959 Looking Escorts In 24/7 Delhi NCR
Call Girls In Nihal Vihar Delhi ❤️8860477959 Looking Escorts In 24/7 Delhi NCR
 
Environmental Biotechnology Topic:- Microbial Biosensor
Environmental Biotechnology Topic:- Microbial BiosensorEnvironmental Biotechnology Topic:- Microbial Biosensor
Environmental Biotechnology Topic:- Microbial Biosensor
 

introductionofpharmacology-141126031620-conversion-gate01.ppt

  • 1. Gollis University Faculty of Agriculture and Veterinary Medicine Introduction to Veterinary Pharmacology LECTURER: Dr.Osman Abdulahi Farah Date: 24 th nov 2014
  • 2. Introduction Pharmacology can be defined as the study of substances that interact with living systems through chemical process, by binding to regulatory molecules activity or inhibiting normal body process.  applications may be considered the proper role of Veterinary pharmacology, which is often defined as the science of substances used to prevent, diagnose, and treat disease for live animals.  Toxicology is that branch of pharmacology which deals with the undesirable effects of chemicals on living systems, from individual cells to complex ecosystems.
  • 3. introduction Veterinary Pharmacology is divided into two main subdivisions, pharmacokinetics and pharmacodynamics . 1.Pharmacodynamics is the study of the actions of drug on target organs. nd way of thinking about it is that pharmacodynamics (PD)is what the drug does to the body,
  • 4. Vet Pharmacokinetics(PK) Vet Pharmacokinetics is What the body does to drug  Modern pharmacology is focused on the biochemical and molecular mechanisms by which drugs produce their physiologic effects and with the dose-response relationship , defined as the relationship between the concentration of a drug in a tissue and the magnitude of the tissue’s response to that drug.
  • 5. continue Most Vet drugs produce their effects by binding to protein receptors in target tissues, a process that activates a flow of events known as signal transduction .
  • 6. Vet Drug Nomenclature Example 1: the chemical name 2-methyl-5- nitroimidazole-l-ethanol is metronidazole. The word methylnitro is condensed to metro and ni- dazole is due to its imidazole ring Example 2: Metoclopramide is the condensed form of the word methoxychloroprocainamide: where Me is retained and th is written as t; chloro is written as clo: and procainamide is written as pramide  Chemical name  represents the exact description of the drug’s chemical composition
  • 7. Generic name Generic name Name that was established when drug was first manufactured Written in lowercase letters Official name of a drug Each drug has only one generic name Original manufacturer is only company that can use generic name for the first 17 years
  • 8. continue  Brand or trade name  is developed by the company requesting approval for the drug and identifies it as the exclusive property of that company.  Is Name under which the drug is sold by a specific manufacturer  Spelling always begins with a capital letter  Name is owned by the drug company and no other company may use that name  Example 1: Metrogyl® is the trade name for metronidazole.  Example 2: Reglan® is the trade name for Metoclopramide.  Example 3: Amoxil® is the trade name for amoxycillin.  Example 4: Celebrex® is the trade name for Celecoxib
  • 9. Pharmacokinetics is the description of the time course of a drug in the body, encompassing Absorption, Distribution, Metabolism, and excretion/Elimination. ADME In simplest terms, it can be described as what the body does to the drug.
  • 10.
  • 11. The relationship between these subdivisions and tissues over time, including drug absorption, distribution, biotransformation (metabolism) , and excretion .
  • 12. Absorption  It is the passage of drug from the site of administration into the circulation.  Bioavailability: is the extend to which a drug reaches its site of action or to biological fluid such as plasma from which the drug has access to its site of action  Aqueous solubility. Drugs given in solid form must dissolve in the aqueous biophase before they are absorbed. For poorly water soluble drugs (aspirin, griseofulvin) the rate of dissolution governs the rate of absorption. If a drug is given as water solution, it is absorbed faster than the same given in solid form or
  • 13. continue  Concentration. Passive transport depends on the concentration gradient. A drug given as concentrated solution is absorbed faster than dilute solution.  Area of absorbing surface. If the area is larger, the absorption is faster  Route of administration affects drug  absorption, because each route has its  own custom
  • 14. Continue  Oral application. Unionized lipid soluble drugs (e.g.ethanol) are readily absorbed from GIT. Acid drugs (aspirin, barbiturates, etc.) are predominantly unionized in the acid gastric juice and are absorbed from the stomach. Acid  drugs absorption from the stomach is slower, because the mucosa is thick, covered with mucus and the surface is small
  • 15. Factors affect drug absorption 1.dose , concentration of rate administration 2. Dosage form 3. Physical and chemical properties 4. Route of administration
  • 16. Distribution  Distribution: is the passage of a drug from the circulation  to the tissue and the site of its action.  The extent of distribution of a drug depends on its lipid solubility, ionization at physiological pH (dependent on pK), extent of binding to plasma and tissue proteins, and differences in regional blood.
  • 17. flow, disease like CHF, uremia, cirrhosis. Movement of a drug proceeds until an equilibration is established between unbound drug in plasma and tissue fluids
  • 18.  Body fluid compartments The total body water as a percentage of body mass varies from 50% to 70%, being rather less in women than in man.  Body water is distributed into the following main compartments
  • 19. Metabolism(Biotransformation)  Metabolism includes chemical alteration of the drugs in the body. Most hydrophilic drugs (amikacin, gentamycin, neostigmine, mannitol) are not biotransformated and are excreted unchanged. The mechanism to metabolize drugs is developed to protect the body from toxins. The primary site for drug metabolism is the liver, other sites are the kidney, intestine, lungs, and plasma  Biotransformation reactions can be classified into two phases: I (no synthetic) and II (synthetic, conjugation).
  • 20. Excretion  Excretion is the passage out of  systematically absorbed drugs.  Vet Drugs and their metabolites  are excreted in:  urine (through the kidney) • bile and faeces • exhaled air • saliva and sweat,milk and skin
  • 21. kidney  The kidney is responsible for excreting all water soluble substances. Glomerular filtration. Glomerular capillaries have large pores. All nonprotein bound drugs (lipid soluble or insoluble) presented to the glomerulus are filtrated. Glomerular filtration of drugs depends on their plasma protein binding and renal blood flow. Glomerular filtration rate (g.f.r.) declines progressively after the age of 50 and is low in renal failure.  Tubular reabsorption. Lipid soluble drugs filtrated at the glomerulus back diffuse in the tubules because 99% of glomerular filtrate is reabsorbed, but nonlipid soluble and highly ionized drugs are unable to do so.
  • 22. continue  The effect of changes in urinary pH on drug excretion  is greatest for a drug having pK values between 5 to 8,  because only in this case pH dependent passive  reabsorption is significant.  Tubular secretion is the active transfer of organic acid and bases by two separate nonspecific mechanisms, which operate in the proximal tubules: • Organic acid transport for penicillins,, methotrexate, drug glucuronides, etc. • Organic base transport for thiazides, quinine,  procainamide, cimetidine, amiloride, etc.
  • 23. Pharmacodynamics Vet Pharmacodynamics is the study of the biochemical and physiological effects of drugs, in certain period. In brief, it can be described as what the drug does to the body. Drug receptors Effects of drug Responses to drugs Toxicity and adverse effects of drugs
  • 24. Drug Receptor Interactions The Lock and Key Model of Signal-Receptor Interaction  Ligands such as hormones or neurotransmitters (the"key") affect target cells by binding to specific receptors (the "lock”), which are often located in the cell membrane of animal body  This binding "unlocks" the cell's response, so that the hormone or neurotransmitter can exert its effects  Agonist “A chemical messenger that binds to a receptor and triggers the cell’s response; often refers to a drug that mimics a normal messenger’s action”.  For example, pilocarpine is a muscarinic receptor agonist because it can bind to and activate muscarinic receptors
  • 25. Drug Receptors  Receptor/Binding site “A specific protein in either the plasma membrane or interior of a target cell with which a ligand/drug combines”  It must be selective in choosing ligands/drugs to bind  To avoid constant activation of the receptor by promiscuous binding of many different ligands (drugs)  It must change its function upon binding in such a way that the function of the biologic system (cell, tissue, etc) is altered  This is necessary for the ligand (drug) to cause a pharmacologic effect
  • 26.  Antagonist is "A molecule that competes for a receptor with a chemical messenger normally present in the body. The antagonist binds to the receptor but does not trigger the cell’s response”  For Example, atropine is a muscarinic receptor antagonist because it can bind to muscarinic receptors but it does not trigger the cell’s response. In this way, it prevents binding of acetylcholine (ACh) and similar agonist drugs to the ACh recept  Any drug will be toxic once they are overdosed.  toxic dose; lethal dose
  • 27. Drug Receptor Interactions Agonist Receptor Agonist- Receptor Lock and key mechanism
  • 28.  Receptor “A specific protein in either the plasma membrane or interior of a target cell with which a chemical messenger/drug combines” Terminology of Pharmacology,  Drug “Any substance that brings about a change in biologic function through its chemical actions”a  Dose “The amount of a drug to be administered at one time” Duration “The time a drug concentration is sufficient to elicit a therapeutic response  Mechanism of Action “The ways by which drugs can produce therapeutic effects”
  • 29. continue  Effects (therapeutic effect) “The desired results of administration of a medication”  Side Effects (adverse effects) “Effects that are harmful and undesired, and that occur in addition to the desired therapeutic effects”  Indications “The reasons for administering a medication or performing a treatment” Contra-indications “Factor that prevents the use of a medication or treatment ( e.g., Allergies)”
  • 30. continue  Onset “The time it takes for the drug to elicit a therapeutic response Bioavailability: is the extend to which a drug reaches its site of action  Pharmacotherapeutics is the medical science concerned with  the use of drugs in the treatment of disease.  Pharmacognosy is the study of drugs isolated from natural sources, including plants, microbes, animal tissues